Biological E Limited (BE) on Tuesday announced a strategic partnership with Bavarian Nordic A/S (OMX: BAVA) to expand access ...

Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...

D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a research report released on Friday,Benzinga reports. The firm currently has a $30.00 target price ...

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for ...

Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...

Hyderabad-based Biological E. Limited (BE) is partnering with Danish firm Bavarian Nordic to expand access to the latter’s ...

Integrating best practices in AI, genomics, cell culture, and laboratory techniques together contribute to protein expression success.

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

Contract manufacturing agreement marks the first step in collaboration to establish supply for expanded access to chikungunya ...